2025 Global Congress
Global Colorectal Cancer Congress
The 2025 Congress will be held virtually on November 12.

2025 Global CRC Congress
Join us virtually, November 12, 2025, for presentations and discussions focused on health equity. We will be learning from expert speakers around the globe, as well as collaborating with one another, highlighting the advocacy efforts that are working in different countries and exploring actionable options in our own countries.
Count Us In: Data, Dignity & Disruption in Global Cancer Equity
Equitable access for all
The 2024 Global CRC Congress exposed a critical flaw in global cancer surveillance: registries relying solely on lab-confirmed cases systematically undercount patients without biopsy access, particularly in low-income and informal communities. This exclusion distorts funding, policy priorities, and healthcare delivery, exacerbating global disparities. The World Health Organization (WHO) confirms this disproportionately impacts low- and middle-income countries (LMICs), where the disease burden is both high and poorly understood. Current methods — periodic surveys, estimations, or paper-based logs — yield intermittent and incomplete datasets. Routine reporting systems are often inadequate, with many LMICs lacking population-based cancer registries, or having registries that only cover select urban/tertiary facilities, leaving rural data uncounted.
"Count Us In" directly addresses these gaps through three pillars:
· Data: Demanding accurate, inclusive registries to replace current undercounts
· Dignity: Centering patient voices and experiences in global cancer care
· Disruption: Challenging systems that perpetuate exclusion
The consequences are severe: Research/clinical trials are compromised by missing data on emerging cancers, genetic/environmental risks, and real-world treatment outcomes. LMICs remain excluded from the research ecosystem, reinforcing disparities. National cancer burdens rely on modeled estimates from incomplete indicators, undermining policy accuracy.
As the 2024 Congress concluded, we were all in agreement that cancer cannot be controlled without being counted. The current fragmentation of data across systems, services, and settings cripples national strategies and global equity efforts. Join us, November 12, for the 2025 Global CRC Congress for presentations and discussions focused on addressing data, dignity, and disruption in global colorectal cancer equity.
"Count Us In" directly addresses these gaps through three pillars:
· Data: Demanding accurate, inclusive registries to replace current undercounts
· Dignity: Centering patient voices and experiences in global cancer care
· Disruption: Challenging systems that perpetuate exclusion
The consequences are severe: Research/clinical trials are compromised by missing data on emerging cancers, genetic/environmental risks, and real-world treatment outcomes. LMICs remain excluded from the research ecosystem, reinforcing disparities. National cancer burdens rely on modeled estimates from incomplete indicators, undermining policy accuracy.
As the 2024 Congress concluded, we were all in agreement that cancer cannot be controlled without being counted. The current fragmentation of data across systems, services, and settings cripples national strategies and global equity efforts. Join us, November 12, for the 2025 Global CRC Congress for presentations and discussions focused on addressing data, dignity, and disruption in global colorectal cancer equity.



















